Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
4
pubmed:dateCreated
2002-8-12
pubmed:abstractText
CAMPATH-1 (CD52)Abs are used in stem-cell transplantation for prevention of GvHD and rejection. The humanized Ab CAMPATH1H has recently replaced the rat Ab CAMPATH-1G. There was a concern whether it might have a longer half-life in vivo and, possibly, cause prolonged immunosuppression post-transplant.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:issn
1465-3249
pubmed:author
pubmed:issnType
Print
pubmed:volume
3
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
261-7
pubmed:dateRevised
2011-11-17
pubmed:meshHeading
pubmed-meshheading:12171714-Adult, pubmed-meshheading:12171714-Antibodies, Monoclonal, pubmed-meshheading:12171714-Antibodies, Monoclonal, Humanized, pubmed-meshheading:12171714-Antibodies, Neoplasm, pubmed-meshheading:12171714-Antigens, CD, pubmed-meshheading:12171714-Antigens, Neoplasm, pubmed-meshheading:12171714-Bone Marrow Purging, pubmed-meshheading:12171714-Bone Marrow Transplantation, pubmed-meshheading:12171714-Cell Count, pubmed-meshheading:12171714-Drug Administration Schedule, pubmed-meshheading:12171714-Female, pubmed-meshheading:12171714-Fluorescent Antibody Technique, Indirect, pubmed-meshheading:12171714-Glycoproteins, pubmed-meshheading:12171714-Graft vs Host Disease, pubmed-meshheading:12171714-Hematopoietic Stem Cell Transplantation, pubmed-meshheading:12171714-Humans, pubmed-meshheading:12171714-Immunosuppression, pubmed-meshheading:12171714-Lymphocyte Depletion, pubmed-meshheading:12171714-Lymphocytes, pubmed-meshheading:12171714-Male, pubmed-meshheading:12171714-Middle Aged, pubmed-meshheading:12171714-Mortality, pubmed-meshheading:12171714-Recovery of Function, pubmed-meshheading:12171714-Retrospective Studies, pubmed-meshheading:12171714-Treatment Outcome
pubmed:year
2001
pubmed:articleTitle
Pharmacokinetics of CAMPATH-1H in BMT patients.
pubmed:affiliation
Sir William Dunn School of Pathology, University of Oxford, UK.
pubmed:publicationType
Journal Article, Clinical Trial, Research Support, Non-U.S. Gov't